A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder

NCT07193563 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Social Anxiety Disorder (SAD)

Interventions

DRUG: ENX-102
OTHER: Placebo

Sponsor

Engrail Therapeutics INC